Category: Medical
-

STAT+: FDA voucher program has become vehicle for political interference in drug review decisions, staffers say
•
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
-

STAT+: Cracking its growth story, Insmed’s nasal inflammation study fails
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about Lilly’s obesity pill, pharma deals with Trump, and much more
•
Top of the morning to you, and a fine one it is. Clear blue skies and pleasant breezes…
-

STAT+: UnitedHealthcare delays controversial RPM policy change
•
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the…
-

STAT+: Eli Lilly’s obesity pill helped patients maintain weight loss after switch from injections
•
Eli Lilly’s investigational obesity pill largely helped patients maintain their weight loss after they switched from the potent…
-

STAT+: Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow
•
When HCA Healthcare, one of the largest hospital systems in the U.S., recently told employees it would stop…
-

STAT+: Meta is urged by state attorneys general to boost enforcement of weight loss drug advertising
•
More than three dozen state attorneys general are urging Meta to better enforce its policies to thwart a…
-

STAT+: FDA approves brain tumor warning on Depo-Provera label as court battle grows over side effects
•
The Food and Drug Administration has approved a change to the labeling for a Pfizer birth control shot…
-

STAT+: More drugmakers set to sign pricing deals with Trump on Friday
•
WASHINGTON — Several drugmakers are expected to sign pricing agreements with the Trump administration on Friday, according to…
-

STAT+: A much-needed win for Pfizer
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about cancer drug trials, Europe’s biotech push, and much more
•
Good morning, everyone, the middle of the week has arrived and this calls for a celebratory cup or…
-

CDC approves new hepatitis B vaccine recommendation as some hospitals reject changes
•
WASHINGTON — The Trump administration on Tuesday adopted its vaccine advisory committee’s recommendation to end the decades-old policy…
-

STAT+: FDA initiates priority voucher for J&J’s ‘Tec-Dara’ combo
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
-

STAT+: Pharmalittle: We’re reading about obesity drug lawsuits, Ramaswamy’s latest startup, and much more
•
Rise and shine, another busy day is on the way. We can tell because the official mascots got…
-

Opinion: We crunched the numbers on drug discovery in the U.S. vs. China. The results were alarming
•
This essay is part of a First Opinion series on the future of the National Institutes of Health…
-

STAT+: Sobi bets big on next-gen gout drug
•
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Recent Posts
- How March Madness foes can end UConn’s run through bracket
- Tournament bets: 12-over-5 upset pick and the 2-seed with clearest path to Elite Eight
- March Madness: Odds, spreads and totals for every men’s opening round games
- One Battle After Another’s big night: Key takeaways from the 2026 Oscars
- Liberia: LDEA Seizes Drugs Worth L$7.77 Million At Ganta Border – Guinean National Arrested
- Nigeria: Why I Didn’t Panic After Losing Power – Sanusi
- Liberia: Police Declare Jackson’s Home ‘Restricted’ As Crime Scene Reconstruction Continues in Wife’s Death Probe
- Liberia: NCD Launches Historic Nationwide Tour to Assess Needs of Persons With Disabilities
- Liberia: CDC Raises Concern Over Foya Border Tension and Accuses Government of Risking National Peace
- Nigeria: 2027 – Tinubu Directs His Campaign Group to Donate Rice to Nigerians for Ramadan, Lent
- Nigeria: Mining Dispute – Govt Accuses Jupiter Ltd of Smear Campaign Plot During Tinubu’s UK Visit
- Nigeria: Nigerian Govt Denies ‘British Lithium Project’ Seizure, Alleges Smear Campaign Ahead of Tinubu’s UK Visit
Social Media
Advertisement




